First Time Loading...

Sonoma Pharmaceuticals Inc
NASDAQ:SNOA

Watchlist Manager
Sonoma Pharmaceuticals Inc Logo
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Watchlist
Price: 0.1601 USD 0.69%
Updated: Apr 30, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

14.6m
+7%
Assets
Growth Rates:
1 Year
+5%
3 Years
-20%
5 Years
-14%
7 Years
-47%
10 Years
+49%
7.9m
-0.4%
Liabilities
Growth Rates:
1 Year
-5%
3 Years
+34%
5 Years
+114%
7 Years
+71%
10 Years
+23%
6.7m
+18%
Equity
Growth Rates:
1 Year
+20%
3 Years
-46%
5 Years
-50%
7 Years
-71%
10 Years
+97%

Balance Sheet Decomposition
Sonoma Pharmaceuticals Inc

14.6m
Assets
7.9m
Liabilities
14.6m
Assets
7.9m
Liabilities
Current Assets 12.5m
Cash & Short-Term Investments 2.4m
Receivables 2.9m
Other Current Assets 7.2m
Non-Current Assets 2.1m
PP&E 738k
Other Non-Current Assets 1.4m
Current Liabilities 3.1m
Accounts Payable 864k
Accrued Liabilities 2m
Short-Term Debt 44k
Other Current Liabilities 138k
Non-Current Liabilities 4.9m
Other Non-Current Liabilities 4.9m

Balance Sheet
Sonoma Pharmaceuticals Inc

Rotate your device to view
Balance Sheet
Currency: USD
Mar-2014 Mar-2015 Mar-2016 Mar-2017 Mar-2018 Mar-2019 Mar-2020 Mar-2021 Mar-2022 Mar-2023
Assets
Cash & Cash Equivalents
5
6
7
17
10
4
4
4
7
4
Cash Equivalents
5
6
7
17
10
4
4
4
7
4
Total Receivables
2
2
2
2
2
4
5
5
5
6
Accounts Receivables
2
2
2
2
2
3
4
3
2
3
Other Receivables
1
0
0
0
0
1
1
2
2
4
Inventory
1
1
2
2
3
3
2
3
3
3
Other Current Assets
1
1
2
1
2
1
1
2
2
1
Total Current Assets
10
10
13
23
16
13
12
13
16
14
PP&E Net
1
1
1
1
1
1
1
1
1
1
PP&E Gross
1
1
0
1
1
1
1
1
1
1
Accumulated Depreciation
3
3
0
3 031
4
4
4
1
2
2
Long-Term Investments
10
5
0
0
0
0
0
0
0
0
Other Long-Term Assets
0
0
0
2
2
1
2
1
2
2
Total Assets
21
N/A
15
-28%
14
-8%
25
+84%
19
-25%
14
-25%
15
+1%
15
+3%
19
+26%
16
-14%
Liabilities
Accounts Payable
1
1
1
1
1
1
2
2
2
1
Accrued Liabilities
1
1
2
541
1
1
1
1
1
2
Short-Term Debt
0
0
0
0
0
0
0
0
1
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
1
0
0
Other Current Liabilities
6
1
1
543
1
1
1
1
2
1
Total Current Liabilities
8
3
4
3
3
4
5
4
6
4
Long-Term Debt
0
0
0
0
0
0
0
1
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
0
0
Other Liabilities
1
0
0
1
0
0
4
4
4
5
Total Liabilities
9
N/A
3
-66%
4
+22%
4
+10%
4
-4%
4
+2%
9
+126%
10
+8%
10
+6%
8
-19%
Equity
Common Stock
0
0
0
0
0
0
0
0
0
0
Retained Earnings
134
142
152
143
157
169
175
179
184
190
Additional Paid In Capital
149
158
166
169
177
184
187
189
197
201
Other Equity
3
4
4
4
4
4
6
5
4
3
Total Equity
12
N/A
12
0%
10
-16%
21
+111%
15
-28%
10
-32%
6
-46%
5
-5%
9
+62%
8
-8%
Total Liabilities & Equity
21
N/A
15
-28%
14
-8%
25
+84%
19
-25%
14
-25%
15
+1%
15
+3%
19
+26%
16
-14%
Shares Outstanding
Common Shares Outstanding
0
0
0
0
1
1
2
2
3
5

See Also

Summary
SNOA intrinsic value, competitors valuation, and company profile.
DCF Valuation
SNOA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SNOA stock valuation using valuation multiples.
Wall Street Estimates
SNOA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SNOA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 132,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.